-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$36.3364.99% Upside
Kiniksa Pharmaceuticals, Ltd. Frequently Asked Questions
-
What analysts cover Kiniksa Pharmaceuticals, Ltd.?
Kiniksa Pharmaceuticals, Ltd. has been rated by research analysts at Evercore ISI, Jefferies, Wells Fargo in the past 90 days.